C
Charles R.V. Tomson
Researcher at Freeman Hospital
Publications - 269
Citations - 11826
Charles R.V. Tomson is an academic researcher from Freeman Hospital. The author has contributed to research in topics: Kidney disease & Renal replacement therapy. The author has an hindex of 47, co-authored 267 publications receiving 9937 citations. Previous affiliations of Charles R.V. Tomson include University of Leicester & University Hospital of Wales.
Papers
More filters
Journal ArticleDOI
The effects of lowering LDL cholesterol with simvastatin plus ezetimibe in patients with chronic kidney disease (Study of Heart and Renal Protection): a randomised placebo-controlled trial
Colin Baigent,Martin J Landray,Christina Reith,Jonathan Emberson,David C. Wheeler,Charles R.V. Tomson,Christoph Wanner,Vera Krane,Alan Cass,Jonathan C. Craig,Bruce Neal,Lixin Jiang,Lai Seong Hooi,Adeera Levin,Lawrence Y. Agodoa,Mike Gaziano,Bertram L. Kasiske,Robert J. Walker,Ziad A. Massy,Bo Feldt-Rasmussen,Udom Krairittichai,Vuddidhej Ophascharoensuk,Bengt Fellström,Hallvard Holdaas,Vladimir Tesar,Andrzej Wiecek,Diederick E. Grobbee,Dick de Zeeuw,Carola Grönhagen-Riska,Tanaji Dasgupta,David Lewis,William G. Herrington,Marion Mafham,William Majoni,K Wallendszus,Richard H. Grimm,Terje R. Pedersen,Jonathan A. Tobert,Jane Armitage,Alex Baxter,Christopher Bray,Yiping Chen,Zhengming Chen,Michael Hill,Carol Knott,Sarah Parish,David Simpson,Peter Sleight,Alan Young,Rory Collins +49 more
TL;DR: Reduction of LDL cholesterol with simvastatin 20 mg plus ezetimibe 10 mg daily safely reduced the incidence of major atherosclerotic events in a wide range of patients with advanced chronic kidney disease.
Journal ArticleDOI
Kidney disease: Improving global outcomes (KDIGO) blood pressure work group. KDIGO clinical practice guideline for the management of blood pressure in chronic kidney disease
Gavin J. Becker,David C. Wheeler,Dick de Zeeuw,Toshiro Fujita,Susan L. Furth,Hallvard Holdaas,Shanthi Mendis,Suzanne Oparil,Vlado Perkovic,Cibele Isaac Saad Rodrigues,Mark J. Sarnak,Guntram Schernthaner,Charles R.V. Tomson,Carmine Zoccali +13 more
Journal ArticleDOI
A randomized controlled study of iron supplementation in patients treated with erythropoietin
Iain C. Macdougall,B. Tucker,Joanne Thompson,Charles R.V. Tomson,L. R. I. Baker,Anthony E.G. Raine +5 more
TL;DR: The results of this study suggest that, even in iron-replete patients, those supplemented with i.v. iron have an enhanced hemoglobin response to EPO with better maintenance of iron stores and lower dosage requirements of EPO, compared with those patients receiving oral iron and no iron supplementation.
Journal ArticleDOI
KDIGO 2021 Clinical Practice Guideline for the Management of Blood Pressure in Chronic Kidney Disease
Alfred K. Cheung,Tara I. Chang,William C. Cushman,Susan L. Furth,Fan Fan Hou,Joachim H. Ix,Gregory A. Knoll,Paul Muntner,Roberto Pecoits-Filho,Mark J. Sarnak,Sheldon W. Tobe,Charles R.V. Tomson,Johannes F.E. Mann +12 more
Journal ArticleDOI
CKD Prevalence Varies across the European General Population
Katharina Brück,Vianda S. Stel,Giovanni Gambaro,Stein Hallan,Henry Völzke,Johan Ärnlöv,Mika Kastarinen,Idris Guessous,José Vinhas,Bénédicte Stengel,Hermann Brenner,Jerzy Chudek,Solfrid Romundstad,Charles R.V. Tomson,Alfonso Otero Gonzalez,Aminu K. Bello,Jean Ferrières,Luigi Palmieri,G Browne,Vincenzo Capuano,Wim Van Biesen,Carmine Zoccali,Ron T. Gansevoort,Gerjan Navis,Dietrich Rothenbacher,Pietro Manuel Ferraro,Dorothea Nitsch,Christoph Wanner,Kitty J Jager +28 more
TL;DR: In this paper, the authors collected data from 19 general-population studies from 13 European countries and investigated international variation in CKD prevalence by age, sex, and presence of diabetes, hypertension, and obesity.